The Antisense Oligonucleotides Decrease Expression of the Cellular Prion

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|7|1|23-26

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.7, Iss.1, 2010-01, pp. : 23-26

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cellular delivery of antisense oligonucleotides

By Lebedeva I.   Benimetskaya L.   Stein C.A.   Vilenchik M.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 50, Iss. 1, 2000-07 ,pp. : 101-119

Elsevier

Access to resources Recommend Favorite

Targeting the Expression of Anti-Apoptotic Proteins by Antisense Oligonucleotides

By  

Current Drug Targets, Vol. 2, Iss. 2, 2001-06 ,pp. : 167-180

Bentham Science Publishers

Access to resources Recommend Favorite

Antisense oligonucleotides to human SQA-neuropeptide FF decrease morphine tolerance and dependence in mice

By Gelot A.   Frances B.   Gicquel S.   Zajac J.-M.  

European Journal of Pharmacology, Vol. 358, Iss. 3, 1998-10 ,pp. : 203-206

Elsevier

Access to resources Recommend Favorite

Antisense oligonucleotides as emerging drugs

By Nyce J.W.  

Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. : 365-376

Informa Healthcare

Access to resources Recommend Favorite

Antisense Oligonucleotides As Therapeutic Agents

By Alama A.   Barbieri F.   Cagnoli M.   Schettini G.  

Pharmacological Research, Vol. 36, Iss. 3, 1997-09 ,pp. : 171-178

Academic Press

Access to resources Recommend Favorite